Laura Maria Guilhoto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Laura Maria Guilhoto has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
Neide Barreira Alonso
Unidade de Pesquisa e Tratamento das Epilepsias (UNIPETE), Universidade Federal de São Paulo - Unifesp, São Paulo, SP, Brazil
4 shared publications- Artur Victor Menezes Sousa
Hospital Geral de Fortaleza, Brazil
3 shared publications - Elza Márcia Targas Yacubian
Department of Neurology and Neurosurgery Universidade Federal de São Paulo São Paulo Brazil
3 shared publications - Adriana Ochoa
Department of Neurogenetics and Molecular Biology, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, Mexico City, Mexico
2 shared publications - Aurelio Jara-Prado
National Institute of Neurology and Neurosurgery, Mexico City, Mexico
2 shared publications Christopher Patterson
GENESS International Consortium Los Angeles CA United States
2 shared publications
Latest Publications
- 5 December 2024
- Published by Wiley in Epileptic Disorders
- Vol. 27 (2) , 228-234
Survey of Latin American ketogenic diet centers: Challenges and success for “La Terapia Cetogénica”
Objective: Despite growing recognition of the efficacy of ketogenic diet therapies (KDT) in reducing seizure frequency and improving the quality of life for individuals with epilepsy, several factors hinder their widespread adoption across Latin America. Specific challenges in the region have been discussed but not formally studied. Currently, no data exist on the availability and operation of KDT teams in the region. To address this gap, we conducted a survey of KDT centers across Latin American countries in the framework of the biannual International Ketogenic Diet Conference in September 2023.Methods: A seven‐question survey was distributed via email to neurologists, dietitians, or through indexed publications.Results: Of the 16 centers approached, 14 (87.5%) responded, identifying 98 KDT centers. Nearly half (49%) are public institutions, primarily in Brazil, Chile, and Mexico; 44 are private; and 5 are mixed. Core teams in all centers included a neurologist and dietitian, with some teams in Argentina, Chile, and Paraguay also involving a medical nutritionist. None of the centers reported a protocol for transitioning to adult care, and consistent data on Glut1 patients and protocols were lacking.Significance: Over the past two decades, the KDT landscape in Latin America has improved, with established centers expanding and new ones emerging. However, continued efforts are needed to promote KDT adoption in countries where it is not yet practiced and in regions with limited resources and expertise.
- 5 December 2024
- Published by Wiley in Epileptic Disorders
- Vol. 27 (2) , 228-234
Survey of Latin American ketogenic diet centers: Challenges and success for “La Terapia Cetogénica”
Objective: Despite growing recognition of the efficacy of ketogenic diet therapies (KDT) in reducing seizure frequency and improving the quality of life for individuals with epilepsy, several factors hinder their widespread adoption across Latin America. Specific challenges in the region have been discussed but not formally studied. Currently, no data exist on the availability and operation of KDT teams in the region. To address this gap, we conducted a survey of KDT centers across Latin American countries in the framework of the biannual International Ketogenic Diet Conference in September 2023.Methods: A seven‐question survey was distributed via email to neurologists, dietitians, or through indexed publications.Results: Of the 16 centers approached, 14 (87.5%) responded, identifying 98 KDT centers. Nearly half (49%) are public institutions, primarily in Brazil, Chile, and Mexico; 44 are private; and 5 are mixed. Core teams in all centers included a neurologist and dietitian, with some teams in Argentina, Chile, and Paraguay also involving a medical nutritionist. None of the centers reported a protocol for transitioning to adult care, and consistent data on Glut1 patients and protocols were lacking.Significance: Over the past two decades, the KDT landscape in Latin America has improved, with established centers expanding and new ones emerging. However, continued efforts are needed to promote KDT adoption in countries where it is not yet practiced and in regions with limited resources and expertise.
- 8 April 2024
- Published by Wiley in Epileptic Disorders
- Vol. 26 (3) , 382-391
A controversial question: Can morphometry and clinical history be enough to diagnose hippocampal dysplasia?
The presence of dysmorphic neurons with strong cytoplasmatic accumulation of heavy non-phosphorylated neurofilament is crucial for the diagnostics of focal cortical dysplasia type II (FCDII). While ILAE's classification describes neocortical dysplasias, some groups have reported patients with mesial t abnormal neurons in the hippocampus of mesial temporal lobe epilepsy. Here we report a patient with such abnormal neurons in the hippocampus and compared it with previous reports of hippocampal dysplasia. Finally, we discuss the need for diagnostic criteria of hippocampal dysplasia.
- 8 April 2024
- Published by Wiley in Epileptic Disorders
- Vol. 26 (3) , 382-391
A controversial question: Can morphometry and clinical history be enough to diagnose hippocampal dysplasia?
The presence of dysmorphic neurons with strong cytoplasmatic accumulation of heavy non-phosphorylated neurofilament is crucial for the diagnostics of focal cortical dysplasia type II (FCDII). While ILAE's classification describes neocortical dysplasias, some groups have reported patients with mesial t abnormal neurons in the hippocampus of mesial temporal lobe epilepsy. Here we report a patient with such abnormal neurons in the hippocampus and compared it with previous reports of hippocampal dysplasia. Finally, we discuss the need for diagnostic criteria of hippocampal dysplasia.
- Open Access
- 28 June 2023
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 81 (06) , 597-606
Ketogenic therapy in childhood and adolescence: recommendations of the Brazilian experts group
Ketogenic dietary therapies (KDTs) are a safe and effective treatment for pharmacoresistant epilepsy in children. There are four principal types of KDTs: the classic KD, the modified Atkins diet (MAD), the medium-chain triglyceride (MCT) diet, and the low glycemic index diet (LGID). The International Ketogenic Diet Study Group recommends managing KDTs in children with epilepsy. However, there are no guidelines that address the specific needs of the Brazilian population. Thus, the Brazilian Child Neurology Association elaborated on these recommendations with the goal of stimulating and expanding the use of the KD in Brazil.
- 28 June 2023
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 81 (06) , 597-606
Open AccessKetogenic therapy in childhood and adolescence: recommendations of the Brazilian experts group
Ketogenic dietary therapies (KDTs) are a safe and effective treatment for pharmacoresistant epilepsy in children. There are four principal types of KDTs: the classic KD, the modified Atkins diet (MAD), the medium-chain triglyceride (MCT) diet, and the low glycemic index diet (LGID). The International Ketogenic Diet Study Group recommends managing KDTs in children with epilepsy. However, there are no guidelines that address the specific needs of the Brazilian population. Thus, the Brazilian Child Neurology Association elaborated on these recommendations with the goal of stimulating and expanding the use of the KD in Brazil.
- 7 April 2023
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 108, 53-59
Minimum effective sodium valproate dose in genetic generalized epilepsies
- 7 April 2023
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 108, 53-59
Minimum effective sodium valproate dose in genetic generalized epilepsies
- 1 September 2021
- Published by Elsevier in Epilepsy & Behavior
- Vol. 122, 108115
COVID-19 and epilepsy: How are people with epilepsy in Brazil?
- 1 September 2021
- Published by Elsevier in Epilepsy & Behavior
- Vol. 122, 108115
COVID-19 and epilepsy: How are people with epilepsy in Brazil?
- 1 July 2021
- Published by Elsevier in Epilepsy & Behavior
- Vol. 120, 107969
Validation of the Health-Related Quality of Life in Childhood Epilepsy Questionnaire (QOLCE-55) for Brazilian Portuguese
- 1 July 2021
- Published by Elsevier in Epilepsy & Behavior
- Vol. 120, 107969
Validation of the Health-Related Quality of Life in Childhood Epilepsy Questionnaire (QOLCE-55) for Brazilian Portuguese
- 1 November 2020
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 82, 125-132
Impulsiveness, personality traits and executive functioning in patients with juvenile myoclonic epilepsy
- 1 November 2020
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 82, 125-132
Impulsiveness, personality traits and executive functioning in patients with juvenile myoclonic epilepsy
- 1 April 2020
- Published by Elsevier in Epilepsy & Behavior
- Vol. 105, 106958
Dysfunctional personality beliefs and executive performance in patients with juvenile myoclonic epilepsy
- 1 April 2020
- Published by Elsevier in Epilepsy & Behavior
- Vol. 105, 106958
Dysfunctional personality beliefs and executive performance in patients with juvenile myoclonic epilepsy